Miroslav Polasek

Articles by Miroslav Polasek

Supplementary Information: Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry

ByGovert W. Somsen,Rob Haselberg,Klara Michalikova,Elena Dominguez-Vega,Miroslav Polasek

February 28th 2019

LCGC Europe

This information is supplementary to the article “Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis-Mass Spectrometry” that was published in the March 2019 issue of LCGC Europe.

Latest Updated Articles

Supplementary Information: Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry
February 28th 2019

Miroslav Polasek

Articles by Miroslav Polasek

Supplementary Information: Middle-Up Characterization of the Monoclonal Antibody Infliximab by Capillary Zone Electrophoresis–Mass Spectrometry

Latest Updated Articles

Trending on LCGC International

Chromatography's Role in Spotting False Leachables

PFAS Method Harmonization: Finding Common Analytical Ground

LC-MS/MS Detects Contaminants in Cat Food

Best of the Week: MS, LC, and GC Insights Roundup

Machine Learning and Predictive CCS Tools for PFAS Identification